Elon Musk's brain enhancement company got rejected for its plans to conduct human trials. In a supposed bid to put things underway, Elon Musk's Neuralink got rejected by the US Food and Drug Administration (FDA) in 2022 for its plans to move forward in testing its technology for humans.